Erratum: CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12 (Leukemia (2012) 26 (1012-1019) DOI: 10.1038/leu.2011.307);CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12

Leukemia

Volumn 26, Issue 5, 2012, Pages 1012-1019

  Mulaw, M A ^a   Krause, A J ^a,g   Deshpande, A J ^a,h   Krause, L F ^a,g   Rouhi, A ^b   La Starza, R ^c   Borkhardt, A ^d   Buske, C ^b   Mecucci, C ^c   Ludwig, W D ^e   Lottaz, C ^f   Bohlander, S K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CALM AF10; genomic instability and DNA repair; GSEA; microarray; myeloid and lymphoid neoplasia

Indexed keywords

CLATHRIN ASSEMBLY PROTEIN LYMPHOID MYELOID LEUKEMIA PROTEIN; DNA; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL COMMUNICATION; CENTROMERE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 10P12; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84860706719     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.171     Document Type: Erratum

References (50)

1. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 1996; 93: 4804-4809.
2. Rosenwald A, Ott G, Krumdiek AK, Dreyling MH, Katzenberger T, Kalla J et al. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas? Genes Chromosomes Cancer 1999; 26: 210-214.
3. Chaplin T, Ayton P, Bernard OA, Saha V, Della Valle V, Hillion J et al. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 1995; 85: 1435-1441.
4. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P et al. Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 2000; 299: 369-378.
5. Saha V, Chaplin T, Gregorini A, Ayton P, Young BD. The leukemia-associatedprotein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc Natl Acad Sci USA 1995; 92: 9737-9741.
6. Greif PA, Tizazu B, Krause A, Kremmer E, Bohlander SK. The leukemogenic CALM//AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 2007; 27: 2886-2896.
7. Lin YH, Kakadia PM, Chen Y, Li YQ, Deshpande AJ, Buske C et al. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias. Blood 2009; 114: 651-658.
8. Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD et al. Molecular basis for sitespecific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006; 442: 91-95.
9. Peñ a PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 2006; 442: 100-103.
10. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823-837.
11. Meyer C, Schneider B, Jakob S, Strehl S, Attarbaschi A, Schnittger S et al. The MLL recombinome of acute leukemias. Leukemia 2006; 20: 777-784.
12. Klebig ML, Wall MD, Potter MD, Rowe EL, Carpenter DA, Rinchik EM. Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice. Proc Natl Acad Sci USA 2003; 100: 8360-8365.
13. Meyerholz A, Hinrichsen L, Groos S, Esk PC, Brandes G, Ungewickell EJ. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 2005; 6: 1225-1234.
14. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 1999; 10: 2687-2702.
15. Ahle S, Ungewickell E. Purification and properties of a new clathrin assembly protein. EMBO J 1986; 5: 3143-3149.
16. Takei K, Mundigl O, Daniell L, De Camilli P. The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin. J Cell Biol 1996; 133: 1237-1250.
17. Carlson KM, Vignon C, Bohlander S, Martinez-Climent JA, Le Beau MM, Rowley JD. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia. Leukemia 2000; 14: 100-104.
18. Deshpande AJ, Cusan M, Rawat VPS, Reuter H, Krause A, Pott C et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 2006; 10: 363-374.
19. Caudell D, Zhang Z, Chung YJ, Aplan PD. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res 2007; 67: 8022-8031.
20. Caudell D, Aplan PD. The role of CALM-AF10 gene fusion in acute leukemia. Leukemia 2008; 22: 678-685.
21. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM et al. hDOT1L links histone methylation to leukemogenesis. Cell 2005; 121: 167-178.
22. Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 2006; 8: 1017-1024.
23. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 2005; 19: 1948-1957.
24. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C et al. CALMAF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003; 102: 1000-1006.
25. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L et al. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 2000; 14: 93-99.
26. Narita M, Shimizu K, Hayashi Y, Taki T, Taniwaki M, Hosoda F et al. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. B J Haematol 1999; 105: 928-937.
27. Salmon-Nguyen F, Busson M, Daniel M, Leblanc T, Bernard OA, Berger R. CALMAF10 fusion gene in leukemias: simple and inversion-associated translocation (10;11). Cancer Genet Cytogenet 2000; 122: 137-140.
28. Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003; 17: 2298-2307.
29. Blatt C, Sachs L. Deletion of a homeobox gene in myeloid leukemias with a deletion in chromosome 2. Biochem Biophys Res Commun 1988; 156: 1265-1270.
30. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714-3725.
31. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274-286.
32. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001; 21: 224-234.
33. Pineault N, Buske C, Feuring-Buske M, Abramovich C, Rosten P, Hogge DE et al. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood 2003; 101: 4529-4538.
34. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 2005; 19: 1948-1957.
35. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991; 65: 737-752.
36. Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H et al. Enhanced selfrenewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004; 21: 843-851.
37. Oguro H, Iwama A, Morita Y, Kamijo T, van Lohuizen M, Nakauchi H. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J Exp Med 2006; 203: 2247-2253.
38. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004; 428: 337-341.
39. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-978.
40. Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, Carro A et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies typespecific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 2008; 93: 670-679.
41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
42. Shimada M, Nakanishi M. DNA damage checkpoints and cancer. J Mol Histol 2006; 37: 253-260.
43. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem 2009; 78: 273-304.
44. Bao Y, Shen X. Chromatin remodeling in DNA double-strand break repair. Curr Opin Genet Dev 2007; 17: 126-131.
45. Misteli T, Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 2009; 10: 243-254.
46. Rodrigue A, Lafrance M, Gauthier MC, McDonald D, Hendzel M, West SC et al. Interplay between human DNA repair proteins at a unique double-strand break in vivo. EMBO J 2006; 25: 222-231.
47. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-313.
48. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414-1418.
49. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-2644.
50. Leroy P, Berto F, Bourget I, Rossi B. Down-regulation of Hox A7 is required for cell adhesion and migration on fibronectin during early HL-60 monocytic differentiation. J Leukoc Biol 2004; 75: 680-688.